Mpho.org

INHALED CONTROLLER MEDICATIONS
Medication Name
Medication Class
Recommendation
Doses-Strengths
♦Pricing
Comments
Aerobid (flunisolide) CFC
$88.38/250mcg
No shaking required; 3 primes to start and reprime after Alvesco (ciclesonide) HFA
Inhaled Corticosteroid (ICS) 12 and older $155.98/160 mcg
10 days without use. Dose indicator in increments of 10 $105.99/110mcg
$130.06/220mcg
Breath actuated device with dose counter; may be given Asmanex (mometasone) DPI*
Inhaled Corticosteroid (ICS) 4-11, 12 and older $140.91/60 metered doses
once daily in PM (110 dose FDA approved for 4-11 yrs) $186.43/120 metered doses
Shake 5 sec.; 2 primes to start; reprime after 3 days Azmacort (triamcinolone) HFA
$152.36/75mcg
Diskus device like Advair, but without serevent; comes in Flovent (fluticasone) DPI*
$99.75/50mcg
only one strengthShake 5 sec.; 4 primes to start; after 7 days without use, 44mcg, 110mcg, 220mcg per $100.74/44mcg
or if dropped, reprime once; Inhaler, often used with Flovent (fluticasone) HFA
$131.73/110mcg
spacer (44-88mcg BID FDA approved for 4-11 yrs); has $214.24/220mcg
Pulmicort (budesonide) DPI*
$103.84/90mcg
New Flexhaler (breath actuated device); has dose counter; Flexhaler
$137.65/180mcg
twist to prime in upright position; two primes to start $191.12/0.25mg
Deliver with closed system mask if < 3 yrs; mask with Pulmicort (budesonide) Respules Inhaled Corticosteroid (ICS) 8 years of age
$224.76/0.5mg
Does not require shaking; 2 primes to start, reprime after 40mcg or 80mcg per actuation $75.59/40mcg
QVAR (beclomethasone) HFA
10 days. Inhaler, recommended to be used without spacer $92.87/80mcg
$175.99/100-50mcg
Advair (fluticasone and
No priming; don't tip once loaded; twice daily dosage (only $209.98/250-50mcg
salmeterol) DPI*
$271.97/500-50mcg
45/21mcg,115/21, 230/21 per $178.76/45-21mcg
Advair (fluticasone and
Shake 5 sec.; 4 primes to start; if dropped, or 4 weeks $208.95/115-21mcg
salmeterol) HFA
without use, 2 test sprays; twice daily dosage $269.91/230-21mcg
Symbicort (budesonide and
$171.99/80-4.5mcg
Shake 5 sec.; 2 primes to start, again after 7 days without formoterol) HFA
$202.37/160-4.5mcg
Serevent (salmeterol) DPI*
$161.30/50mcg
Not be used for quick relief or without ICS in asthma
Foradil (formoterol) DPI*
$161.20/12mcg
Not be used for quick relief or without ICS in asthma
Brovana (arformoterol) nebulized Long-acting beta2-agonist
$56.25/5- 18mcg
Spiriva (tiotropium)*
Once daily; should avoid use with Combivent or Duoneb $197.16/30- 18mcg
* Contains lactose
INHALED QUICK RELIEF MEDICATIONS
Medication Name
Medication Class
Recommendation
Doses-Strengths
♦Pricing
Comments
AccuNeb (albuterol for
$49.13/0.63mg/3ml
nebulization)
$50.99/1.25mg/3ml
Shake 5 sec.; 4 primes to start; reprime after 4 weeks Albuterol CFC
$15.99/2mg tablets
Albuterol Nebulized 0.083%
$18.99/0.083%
Albuterol Nebulized 0.5%
$15.99/0.5%
Shake 5 sec.; 2 primes to start; 2 primes after 2 days Maxair (pirbuterol) CFC
$115.99/200mcg
Shake 5 sec.; 3 primes to start; reprime after 14 days ProAir (albuterol sulfate) HFA
$41.84/90mcg
Shake 5 sec.; 4 primes to start; reprime after 2 weeks Proventil (albuterol sulfate) HFA
$52.02/90mcg
Shake 5 sec.; 4 primes to start; reprime if dropped or after Ventolin (albuterol sulfate) HFA
$37.99/90mcg
Shake 5 sec.; 4 primes to start; 4 primes after 3 days Xopenex (levalbuterol) HFA
$53.84/45mcg
$100.11/0.31mg/3ml
Xopenex Nebulized (levalbuterol) Short-acting beta2-agonist
$102.78/0.63mg/3ml
Unit dose for nebulization; needs no mixing $101.59/1.25mg/3ml
Atrovent (ipratropium) HFA
$117.62/17mcg
2 primes to start; 2 primes after 3 days without use Combivent (ipratropium and
$127.03/103-18mcg
Shake 10 sec.; 3 primes to start; 3 primes after 24 hours albuterol) CFC
Duoneb (ipratropium and
$40.00/0.5-2.5mg/3ml
albuterol)
♦Pricing Source: Prices noted are from April 2009, www.drugstore.com. Actual prices will vary by retail pharmacy and likely change over time. Not all prices for doses listed above are available.
Source: medication package insertThis document is intended to comprise most frequently used medication in the MaineHealth system.

Source: http://www.mpho.org/resource/d/69316/AsthmaMedicationPricingGuide09Levi.pdf

Microsoft word - aulikki herneoja_theory-guided content analysis.doc[1].doc

Theory-guided Content Analysis in Architectural Research Case: The Colouration of the Home During the Post-War Reconstruction Period: The Everyday and Architecture. Aulikki HERNEOJA Head of Laboratory of Art end Design, Doctor of Science (Technology), Architect University of Oulu, Department of Architecture Postal address: Aulikki Herneoja, University of Oulu, Department of

Pii: s0090-4295(02)01903-9

PEDIATRIC UROLOGY PROSPECTIVE COMPARISON AND 1-YEAR FOLLOW-UP OFDEXTRANOMER/HYALURONIC ACID COPOLYMER INJECTIONFOR TREATMENT OF VESICOURETERAL REFLUX IN CHILDRENJ. OSWALD, M. RICCABONA, L. LUSUARDI, G. BARTSCH, AND C. RADMAYR ABSTRACT Objectives. To compare, in a prospective study, the efficacy of a single injection of polydimethylsiloxane (Macroplastique) or dextranomer/hyaluronic ac

Copyright © 2010-2014 Medical Articles